[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Post-Traumatic Stress Disorder Treatment Market Size, Trends, Analysis, and Outlook By Drug Class (Antidepressants, Antipsychotics, Anti-anxiety, Others), By Demographics (Adult, Children), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), by Region, Country, Segment, and Companies, 2024-2030

March 2024 | 190 pages | ID: P07168C4205BEN
VPAResearch

US$ 3,980.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Post-Traumatic Stress Disorder Treatment market size is poised to register 5% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Post-Traumatic Stress Disorder Treatment market across By Drug Class (Antidepressants, Antipsychotics, Anti-anxiety, Others), By Demographics (Adult, Children), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others).

The Post-Traumatic Stress Disorder (PTSD) Treatment market is expanding due to the growing recognition of PTSD as a public health concern and the development of targeted therapeutic interventions. PTSD is a psychiatric disorder that can develop following exposure to traumatic events, such as combat, natural disasters, or interpersonal violence. Treatment modalities include psychotherapy, pharmacotherapy, and emerging approaches like virtual reality therapy and mindfulness-based interventions. With increasing efforts to destigmatize mental health conditions and improve access to care, the PTSD treatment market is expected to witness continued growth.

Post-Traumatic Stress Disorder Treatment Market Drivers, Trends, Opportunities, and Growth Opportunities

This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Post-Traumatic Stress Disorder Treatment market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Post-Traumatic Stress Disorder Treatment survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Post-Traumatic Stress Disorder Treatment industry.

Key market trends defining the global Post-Traumatic Stress Disorder Treatment demand in 2024 and Beyond

The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.

Post-Traumatic Stress Disorder Treatment Market Segmentation- Industry Share, Market Size, and Outlook to 2030

The Post-Traumatic Stress Disorder Treatment industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Post-Traumatic Stress Disorder Treatment companies scaling up production in these sub-segments with a focus on expanding into emerging countries.

Key strategies adopted by companies within the Post-Traumatic Stress Disorder Treatment industry

Leading Post-Traumatic Stress Disorder Treatment companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Post-Traumatic Stress Disorder Treatment companies.

Post-Traumatic Stress Disorder Treatment Market Study- Strategic Analysis Review

The Post-Traumatic Stress Disorder Treatment market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
  • Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
  • Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
  • Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
  • Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
Post-Traumatic Stress Disorder Treatment Market Size Outlook- Historic and Forecast Revenue in Three Cases

The Post-Traumatic Stress Disorder Treatment industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.

Post-Traumatic Stress Disorder Treatment Country Analysis and Revenue Outlook to 2030

The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.

North America Post-Traumatic Stress Disorder Treatment Market Size Outlook- Companies plan for focused investments in a changing environment

The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Post-Traumatic Stress Disorder Treatment market segments. Similarly, Strong end-user demand is encouraging Canadian Post-Traumatic Stress Disorder Treatment companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Post-Traumatic Stress Disorder Treatment market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.

Europe Post-Traumatic Stress Disorder Treatment Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities

The German industry remains the major market for companies in the European Post-Traumatic Stress Disorder Treatment industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Post-Traumatic Stress Disorder Treatment market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.

Asia Pacific Post-Traumatic Stress Disorder Treatment Market Size Outlook- an attractive hub for opportunities for both local and global companies

The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Post-Traumatic Stress Disorder Treatment in Asia Pacific. In particular, China, India, and South East Asian Post-Traumatic Stress Disorder Treatment markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.

Latin America Post-Traumatic Stress Disorder Treatment Market Size Outlook- Continued urbanization and rising income levels

Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.

Middle East and Africa Post-Traumatic Stress Disorder Treatment Market Size Outlook- continues its upward trajectory across segments

Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Post-Traumatic Stress Disorder Treatment market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Post-Traumatic Stress Disorder Treatment.

Post-Traumatic Stress Disorder Treatment Market Company Profiles

The global Post-Traumatic Stress Disorder Treatment market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Aptinyx , AstraZeneca, Aurobindo Pharma Ltd, Bionomics, GlaxoSmithKline Plc, Jazz Pharmaceuticals, Lupin Ltd, Merck KGaA, Otsuka Pharmaceutical Development, Pfizer Inc

Recent Post-Traumatic Stress Disorder Treatment Market Developments

The global Post-Traumatic Stress Disorder Treatment market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.

Post-Traumatic Stress Disorder Treatment Market Report Scope

Parameters: Revenue, Volume Price

Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)

Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)

Qualitative Analysis
  • Pricing Analysis
  • Value Chain Analysis
  • SWOT Profile
  • Market Dynamics- Trends, Drivers, Challenges
  • Porter’s Five Forces Analysis
  • Macroeconomic Impact Analysis
  • Case Scenarios- Low, Base, High
Market Segmentation:

By Drug Class

Antidepressants

Antipsychotics

Anti-anxiety

Others

By Demographics

Adult

Children

By Distribution Channel

Hospital Pharmacy

Retail Pharmacy

Others

Geographical Segmentation:
  • North America (3 markets)
  • Europe (6 markets)
  • Asia Pacific (6 markets)
  • Latin America (3 markets)
  • Middle East Africa (5 markets)
Companies

Aptinyx

AstraZeneca

Aurobindo Pharma Ltd

Bionomics

GlaxoSmithKline Plc

Jazz Pharmaceuticals

Lupin Ltd

Merck KGaA

Otsuka Pharmaceutical Development

Pfizer Inc

Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY

1.1 Post-Traumatic Stress Disorder Treatment Market Overview and Key Findings, 2024
1.2 Post-Traumatic Stress Disorder Treatment Market Size and Growth Outlook, 2021- 2030
1.3 Post-Traumatic Stress Disorder Treatment Market Growth Opportunities to 2030
1.4 Key Post-Traumatic Stress Disorder Treatment Market Trends and Challenges
  1.4.1 Post-Traumatic Stress Disorder Treatment Market Drivers and Trends
  1.4.2 Post-Traumatic Stress Disorder Treatment Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Post-Traumatic Stress Disorder Treatment Companies

2. POST-TRAUMATIC STRESS DISORDER TREATMENT MARKET SIZE OUTLOOK TO 2030

2.1 Post-Traumatic Stress Disorder Treatment Market Size Outlook, USD Million, 2021- 2030
2.2 Post-Traumatic Stress Disorder Treatment Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024

3. POST-TRAUMATIC STRESS DISORDER TREATMENT MARKET- STRATEGIC ANALYSIS REVIEW

3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis

4. POST-TRAUMATIC STRESS DISORDER TREATMENT MARKET SEGMENTATION ANALYSIS AND OUTLOOK

4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Drug Class
Antidepressants
Antipsychotics
Anti-anxiety
Others
By Demographics
Adult
Children
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030

5. REGION-WISE MARKET OUTLOOK TO 2030

5.1 Key Findings for Asia Pacific Post-Traumatic Stress Disorder Treatment Market, 2025
5.2 Asia Pacific Post-Traumatic Stress Disorder Treatment Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Post-Traumatic Stress Disorder Treatment Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Post-Traumatic Stress Disorder Treatment Market, 2025
5.5 Europe Post-Traumatic Stress Disorder Treatment Market Size Outlook by Type, 2021- 2030
5.6 Europe Post-Traumatic Stress Disorder Treatment Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Post-Traumatic Stress Disorder Treatment Market, 2025
5.8 North America Post-Traumatic Stress Disorder Treatment Market Size Outlook by Type, 2021- 2030
5.9 North America Post-Traumatic Stress Disorder Treatment Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Post-Traumatic Stress Disorder Treatment Market, 2025
5.11 South America Pacific Post-Traumatic Stress Disorder Treatment Market Size Outlook by Type, 2021- 2030
5.12 South America Post-Traumatic Stress Disorder Treatment Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Post-Traumatic Stress Disorder Treatment Market, 2025
5.14 Middle East Africa Post-Traumatic Stress Disorder Treatment Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Post-Traumatic Stress Disorder Treatment Market Size Outlook by Application, 2021- 2030

6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030

6.1 US Post-Traumatic Stress Disorder Treatment Market Size Outlook and Revenue Growth Forecasts
6.2 US Post-Traumatic Stress Disorder Treatment Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Post-Traumatic Stress Disorder Treatment Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Post-Traumatic Stress Disorder Treatment Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Post-Traumatic Stress Disorder Treatment Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Post-Traumatic Stress Disorder Treatment Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Post-Traumatic Stress Disorder Treatment Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Post-Traumatic Stress Disorder Treatment Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Post-Traumatic Stress Disorder Treatment Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Post-Traumatic Stress Disorder Treatment Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Post-Traumatic Stress Disorder Treatment Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Post-Traumatic Stress Disorder Treatment Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Post-Traumatic Stress Disorder Treatment Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Post-Traumatic Stress Disorder Treatment Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Post-Traumatic Stress Disorder Treatment Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Post-Traumatic Stress Disorder Treatment Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Post-Traumatic Stress Disorder Treatment Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Post-Traumatic Stress Disorder Treatment Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Post-Traumatic Stress Disorder Treatment Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Post-Traumatic Stress Disorder Treatment Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Post-Traumatic Stress Disorder Treatment Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Post-Traumatic Stress Disorder Treatment Industry Drivers and Opportunities

7. POST-TRAUMATIC STRESS DISORDER TREATMENT MARKET OUTLOOK ACROSS SCENARIOS

7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case

8. POST-TRAUMATIC STRESS DISORDER TREATMENT COMPANY PROFILES

8.1 Profiles of Leading Post-Traumatic Stress Disorder Treatment Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Aptinyx
AstraZeneca
Aurobindo Pharma Ltd
Bionomics
GlaxoSmithKline Plc
Jazz Pharmaceuticals
Lupin Ltd
Merck KGaA
Otsuka Pharmaceutical Development
Pfizer Inc

9. APPENDIX

9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information


More Publications